Recurrences Completed Phase 4 Trials for Venlafaxine (DB00285)

Also known as: Recurrence

IndicationStatusPhase
DBCOND0050633 (Recurrences)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00046020Study Evaluating Venlafaxine ER in Recurrent DepressionTreatment